| |
|
|
|
Xtalks, Online
2025-04-22
Interstitial lung disease (ILD) represents a diverse group of disorders characterized by infiltration of lung parenchyma with extracellular matrix, leading to progressive respiratory impairment and respiratory failure over time.
Patients often experience debilitating symptoms such as breathlessness and chronic cough, significantly affecting their quality of life and limiting daily activities. Treatment options for ILD are limited and vary based on disease etiology and progression. While antifibrotic agents such as nintedanib and pirfenidone have shown efficacy in slowing disease progression, there remains a significant unmet need with novel therapies directed at both underlying pathophysiology and symptomatic relief under active clinical development.
The application of meaningful and measurable endpoints is essential for the success of ILD clinical trials. However, regulatory challenges persist, particularly in validating novel digital biomarkers and patient-reported outcomes (PROs). Regulatory agencies emphasize the need for standardized, reproducible measures that demonstrate clinical relevance, necessitating rigorous validation studies and alignment with evolving guidelines for digital health technologies (DHTs) in clinical trials.
Read more...
Register for this webinar to learn about the latest advancements in ILD clinical trial design from endpoint selection and novel cough monitoring tech to patient-centric trial design and imaging solutions.
Keywords: Clinical Trials, Drug Development, Lung Disease, Clinical Research, CRO, Patient Recruitment, Biomarkers, Respiratory Disease, Regulatory, Respiratory, Lung Function, Chronic Lung Diseases, Sites
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Dr. Todd Lustine, MD, MS, FCCP, Vice President, Medical Science, Respiratory, Clario
Kevin McCarthy, RPFT, Director, Scientific Affairs, Clario
Amit Vasanji, PhD, Vice President, Medical & Scientific Affairs, Clario
Dr. Peter Cho, PhD, MRCP, FHEA, Adjunct Senior Lecturer, Kings College Hospital NHSFT
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-04-22
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|